Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 2Phase 3 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 2Breast Neoplasms 2Agnosia 2Rectal Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 149Docetaxel 138Paclitaxel 127Trastuzumab 119Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Propofol × Clear all
NCT00418457 2020-06-16

Regional Anesthesia and Breast Cancer Recurrence

The Cleveland Clinic

Phase 3 Completed
2,108 enrolled 12 charts
Breast

Agnosia, Breast Neoplasms

NCT00542542 2015-04-13

Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

M.D. Anderson Cancer Center

Phase 3 Completed
89 enrolled 3 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡